Severe cutaneous adverse reaction associated with vemurafenib: <scp>DRESS</scp>,<scp> AGEP</scp> or overlap reaction?A. Gey, Thomas Jouary, Caroline Robert et al.|Journal of the European Academy of Dermatology and Venereology|2014Cited by 30
Adverse events need for hospitalization and systemic immunosuppression in very elderly patients (over 80 years) treated with ipilimumab for metastatic melanomaVaianu Leroy, Anne Pham‐Ledard, M. Beylot‐Barry et al.|Cancer Immunology Immunotherapy|2019Cited by 22
Tolérance et efficacité de l’ipilimumab chez les patients âgésV. Leroy-Colavolpe, Anne Pham‐Ledard, M. Beylot‐Barry et al.|Annales de Dermatologie et de Vénéréologie|2016Cited by 2